Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,845 | 116,616 | 123,794 | 146,877 | 174,559 |
| Receivables | 286,154 | 281,159 | 248,855 | 264,563 | 265,012 |
| Inventories | 196,876 | 189,468 | 173,303 | 179,684 | 176,487 |
| Other current assets | 118,423 | 110,403 | 108,220 | 113,073 | 123,774 |
| TOTAL | $712,298 | $697,646 | $654,172 | $704,197 | $739,832 |
| Non-Current Assets | |||||
| PPE Net | 469,982 | 449,103 | 437,270 | 409,980 | 394,021 |
| Intangibles | 253,146 | 254,016 | 256,314 | 258,466 | 39,036 |
| Other Non-Current Assets | 288,811 | 280,203 | 189,593 | 171,887 | 347,796 |
| TOTAL | $1,011,939 | $983,322 | $883,177 | $840,333 | $780,853 |
| Total Assets | $1,724,237 | $1,680,968 | $1,537,349 | $1,544,530 | $1,520,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 67,606 | 70,143 | 69,534 | 65,457 | 68,015 |
| Accrued Expenses | 256,329 | 229,127 | 260,683 | 238,431 | 228,380 |
| TOTAL | $618,909 | $689,619 | $770,444 | $759,537 | $774,316 |
| Non-Current Liabilities | |||||
| Long Term Debt | 700,552 | 699,334 | 601,348 | 664,963 | 603,130 |
| Deferred Revenues | 43,446 | 43,351 | 41,290 | 41,149 | 40,921 |
| Other Non-Current Liabilities | 148,688 | 151,491 | 84,787 | 81,531 | 83,278 |
| TOTAL | $933,779 | $939,479 | $776,138 | $786,356 | $787,218 |
| Total Liabilities | $1,552,688 | $1,629,098 | $1,546,582 | $1,545,893 | $1,561,534 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,090 | 86,006 | 86,007 | 86,234 | 86,591 |
| Common Shares | 10,548 | 10,535 | 10,509 | 10,504 | 10,485 |
| Retained earnings | 1,396,315 | 1,270,609 | 1,167,928 | 1,082,292 | 989,039 |
| Other shareholders' equity | -36,276 | -35,149 | -36,886 | -37,643 | -37,530 |
| TOTAL | $171,549 | $51,870 | $-9,233 | $-1,363 | $-40,849 |
| Total Liabilities And Equity | $1,724,237 | $1,680,968 | $1,537,349 | $1,544,530 | $1,520,685 |